Replies to post #46130 on Cytodyn Inc (CYDY)

[Fortuno]

You’re probably right. Some things never change.

[The Lawman]

"Slippery" is a very charitable way of describing Pourhassan in my opinion, Saltz.

If Pourhassan believed in the company and Leronlimab as much as he claims, he would have presumably purchased some stock on the open market.

With a 50% raise, Pourhassan no longer has any excuse--not that he did before--for not purchasing stock.

How Pourhassan managed to finagle a 50% raise, and a total compensation package of $1.5M is astounding given how shareholders have suffered under his watch.

In the back of my mind I cannot help but wonder if Pourhassan might possibly be conning the investors to keep his compensation flowing.

Saltz, I, like you, tendered all of my warrants based upon Pourhassan's litany of good news at the time, little of which has come to fruition.

While I continue to believe in the science, I continue to distrust Pourhassan, and have serious concerns about his ability to lead this company to a successful conclusion.

LM

[weasel6667]

If you would have written this a year ago, the Pro Nader crowd would have been all over you. Naysayer, shortseller, flipper etc. ...
Some have argued for some time that those Proactive- Investor interviews do not really provide any value, just distraction for his crowd on ihub and ihangout (check the viewcount on youtube). If a timeline approaches he cannot keep he pulls out new carrots and his crowd is satisfied until the next carrot.
For some here it was quite controversial when he raised his salary in the beginning of the year, some argued he earned it by getting Pestell on board and the test which will generate revenues in a few months. Yeah, it was the other way round, Pestell approached CYDY and what mess happened with Pestell we can just imagine or guess at this time.

The Nader crowd also praises him, because he just raises so much money as needed to get us to the finish line. In reality he raises as much money as possible each time (see the TO results). In my opinion the financing mess was created way back in the past, by Nader getting addicted to Paulson (easy money). The resulting longtime shareprice damage due to this raises was/ is considerable.

The FDA excuse is also getting slowly a beard.
On the one side the Nader crowd argues Nader has a good connection / relationship with FDA and Nader is therefore not replaceable. Then a few weeks later they use the FDA as an excuse that we are delayed again. You cannot have it both ways.

Nader gets now paid 1.5M$/ year and his damn job is to get us over (not near) the finish line and not to find excuses. If he cannot find a way to handle the FDA, then he should step back or get some help (connections are everything in this business).
At the moment FDA is playing with us and I am wondering if this is due to Naders inexperience.